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BACKGROUND፡ Pregnancy induced hypertension represents a 
significant public health problem throughout the world, which 
may complicate 0.5%–10% of all pregnancies. It is the leading 
cause of maternal as well perinatal mortality and morbidity 
worldwide. Pregnancy induced hypertension is a multisystem 
disorder unique to pregnancy and results in high perinatal 
mortality. The objective of this study was to determine the survival 
status, incidence and predictors of perinatal mortality among 
mothers with pregnancy induced hypertension at antenatal clinics 
of Gamo Zone public hospitals. 
METHODS: Facility-based retrospective cohort study was 
conducted among selected 576(192 exposed and 384 unexposed) 
antenatal care attendants' record at Gamo Zone public hospitals 
from 1st January 2018 to 31st December 2018. Data were entered 
into Epi data version 3.02 and exported to SPSS V 25 for analysis. 
Kaplan Meier survival curve together with log rank test was fitted 
to test the survival time. Statistical significance was declared at P-
value <0.05 using cox proportional hazard model. 
RESULT: The incidence of perinatal mortality was 124/1000 
births. The cumulative proportion of surviving at the end of 4th , 
8th, 12th and 16th weeks of follow-up among the exposed groups 
was 96.9%, 93.5%, 82.1% and 61.6% respectively whereas it was 
99.5%, 98.9% and 98.5% at the end of 4th, 8th and 12th weeks of 
follow-up for the non-exposed groups respectively. Parity of 
>5(AHR: 6.3; 95%CI: 1.36,10.55), mothers who delivered at <34 
weeks of gestation(AHR:7.8; 95%CI: 2.6,23.1), being 
preterm(AHR:6; 95%CI: 5.3,19.2), perinatal birth weight 
<2500gm(AHR:6.1; 95&CI: 1.01,37.9), vaginal 
deliveryn(AHR:2.7; 95%CI:1.13,6.84), maternal highest systolic 
blood pressure level >160mmHg (AHR: 2.3; 95%CI: 1.02,5.55) 
and prepartum onset of pregnancy induced hypertension (AHR: 
6; 95%CI: 5.3,19.2) were statistically significant in multivariable 
analysis.  
CONCLUSION: The risk of perinatal mortality was high among 
the mothers with pregnancy induced hypertension compared to 
those of pregnancy induced hypertension free mother,s and the 
  
                  
                    Ethiop J Health Sci.                           Vol. 30, No. 6                          November 2020 
 




perinatal mortality rate was high. High parity, 
low gestational age, low number of antenatal 
care visits, low birth weight, vaginal delivery, 
antepartum onset of pregnancy induced 
hypertension and highest maternal systolic 
blood pressure level were the independent 
predictors of perinatal mortality.  
KEYWORDS: Incidence; Predictors; Perinatal 




Pregnancy Induced Hypertension (PIH) is a term 
used to define a wide spectrum of women who 
may have only mild elevations in blood pressure 
(BP) or severe Hypertension (HTN) with various 
organ dysfunctions (1). It complicates nearly 
0.5%–10% of all pregnancies, which is the 
leading causes of maternal and perinatal 
mortality and morbidity worldwide (2).  
Preeclampsia and eclampsia are the 
most common complications of pregnancy 
induced hypertension; and are the recognized 
causes of maternal and newborn morbidity and 
mortality in low and middle income countries. 
Preeclampsia can be present as HELLP 
syndrome (hemolysis, elevated liver enzymes 
and low platelet count) or eclampsia that is 
occurrence of convulsions that cannot be 
attributed to other etiologic factors (1). 
According to the 2017 world 
preeclampsia day report, as a leading cause of 
maternal mortality, preeclampsia and related 
pregnancy induced hypertension claim the lives 
of nearly 76,000 mothers and 500,000 babies 
worldwide every year (3). Magnesium sulfate is 
the drug recommended for the prevention of 
complications (seizure) as part of comprehensive 
management of pregnancy induced hypertension 
(4). 
According to the World Health Organization 
(WHO), multi-country survey, there was about 
three-fold increased risk of perinatal death in 
women with preeclampsia and five-fold 
increased risk of perinatal death in women with 
eclampsia compared to women with no 
preeclampsia or eclampsia (2). The majority of 
perinatal deaths due to complications of PIH 
have occurred in the low income and middle 
income countries.  
In Ethiopia, the complications of PIH 
are major causes of maternal and perinatal 
morbidities and mortalities. PIH is one of the 
significant public health problems throughout 
the world, and preeclampsia is the most common 
of these problems (5). 
Ethiopia is one of the countries in sub-
Saharan Africa having high perinatal mortality. 
A study conducted on trend of perinatal 
mortality rate revealed that a rate of 90 and 40 
per 1000 birth in hospital and community-based 
settings respectively (5), and according to EDHS 
2016, it was 33 per 1000 pregnancies (6). In 
addition, the progress in reduction in rate of still 
birth was too much poor. The Ethiopian 
Demographic and Health Survey (EDHS) 2000, 
2011 and 2016 revealed that the rate of still birth 
was 10.4, 16.9 and 11 per 1000 births 
respectively (6,7,8). Similarly, a study 
conducted in the southern part of Ethiopia 
reported that there was a considerable 
association between perinatal deaths and low 
birth weight (9).  Obstetric related factors and 
pregnancy induced hypertension related factors 
were the most common factors affecting the 
perinatal survival status. Therefore, the objective 
of this study was to determine the survival time, 
incidence and predictors of perinatal mortality 
among mothers with pregnancy induced 
hypertension at antenatal care clinics of Gamo 
Zone public hospitals from January 01, 2018 to 




Study design, area and period: A retrospective 
cohort study was conducted at Gamo Zone 
public hospitals from 1st January, 2018 to 31st 
December, 2018. Gamo Zone is one of the zones 
found in South Nations Nationalities and 
People’s Regional State (SNNPRS). The zone 
has 3 hospitals (Arba Minch General Hospital, 
Kemba Primary Hospital and Chencha District 
Hospital).  
 
Population: All records of Antenatal Care 
(ANC) attendant pregnant mothers who had PIH 
at Gamo Zone public hospitals were considered 
as the source population, and the study 
population was all the selected records of 
antenatal care attendant pregnant mothers who 
had PIH at Gamo Zone public hospitals. Records 
 








of antenatal care attendant pregnant mothers 
who had PIH at Gamo Zone public hospitals 
were considered as exposed groups, and records 
of pregnancy induced hypertension free 
antenatal care attendant pregnant mothers were 
considered as unexposed groups. 
 
Selection of study subjects: All babies born 
from mothers who had ANC visit at Gamo Zone 
public hospitals from 1st January, 2018 to 31st 
December, 2018 were included in the study and 
babies born before 28 weeks of gestation, babies 
born from mothers who had chronic 
hypertension before pregnancy and incomplete 
records were excluded from the study. The 
diagnosis of PIH was made by the physicians 
and midwives working in the unit. It was an 
open cohort, and exposed subjects were entered 
into the cohort at the time on the diagnosis of 
pregnancy induced hypertension and unexposed 
one were entered at any time of the follow-up 
period. In addition, subjects exited from the 
cohort when discharged as cured at the end of 
treatment declared or died.  
 
Sample size determination and sampling 
procedure: Arba Minch General Hospital and 
Chencha District Hospital were selected for this 
study using lottery method among hospitals at 
Gamo Zone. Within this hospital, there were 192 
mothers who had PIH. Therefore, all the mothers 
who had PIH were taken as exposed group, and 
for each of the exposed group, two consecutive 
members of the unexposed group were taken for 
comparison. This yielded 576 (192 exposed and 
384 unexposed groups) respondents. 
 
Study variables: The dependent variable was 
time to perinatal death. The independent 
variables were categorized into obstetric related 
factors, PIH and related factors an (maternal age, 
parity, gestational age, number of ANC visits, 
labour onset, number of fetuses, mode of 
delivery and fetal birth weight) and PIH related 
factors (highest systolic blood pressure level, 
highest diastolic blood pressure level, type of 
PIH, onset of PIH, severity symptoms of PIH, 
type of anticonvulsant given, type of 
antihypertensive given and maternal hemoglobin 
level).  
DEFINITION OF TERMS 
 
Perinatal death: The death of a fetus/neonate in 
the perinatal period (from age of viability or 
twenty eight weeks of gestation in Ethiopian 
context to first six days after birth) (8). 
Pregnancy induced hypertension: A new 
hypertension that appears at 20 weeks or more 
gestational age of pregnancy with or without 
proteinuria, which includes gestational 
hypertension, preeclampsia and eclampsia (9). 
 
Data collection tool and Procedure: Data were 
collected using a questionnaire prepared specific 
to this study using individual patient records 
including registers, monitoring cards and patient 
admission book and appropriate modification 
was made. In addition, the tool contains 
maternal age, obstetric related factors, 
pregnancy induced hypertension related factors 
and basic laboratory findings. The data were 
collected by four researchers (midwives) a
supervised by two researchers (midwives) who 
were trained on basic emergency mother and 
neonatal care.  
 
Data processing and analysis: Data were 
cleaned, edited, coded and entered into Epi data 
version 3.02 and exported to SPSS v 25 for 
analysis.  Bivariate analysis was conducted to 
identify associations between dependent and 
independent variables. Hazard ratios, 95% CIs 
and P-values were used to assess the strength of 
association and statistical significance. Incidence 
of death was calculated. Variables which had p-
value <0.25 level in the bivariate analysis were 
included in the final Cox-regression analysis. 
Variables that had a p-value of ≤0.05 in the 
multivariable analysis were considered as 
independent predictors of perinatal mortality in 
the final Cox-regression analysis. 
 
Ethical consideration: Ethical clearance was 
obtained from Arba Minch College of Health 
Science Ethical Review Committee, and support 
letter was obtained prior to data collection. 
Permission letter was obtained from Gamo 
Zone Health Department. The administrators 
of Arba Minch General Hospital and Chencha 
District Hospital were informed about the 
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objective of the study through a support letter. 
All the appropriate efforts were made to handle 




This study included 576 (192 exposed and 384 
unexposed) antenatal care attending pregnant 
mothers. The mothers gave a total of 595 babies 
(19 sets of twins and all the twins were from the 
unexposed groups) after 28 weeks of gestation. 
Specific to this study, there were 74 perinatal 
deaths resulting in a Perinatal Mortality Rate 
(PMR) of 124/1000 total births. 
The distribution of PIH by type was 
mild preeclampsia 100(17.4%), sever 
preeclampsia 61(10.6%) and eclampsia 
31(5.4%). However, the case fatality rate of 
preeclampsia (10%) was significantly lower than 
sever preeclampsia(63%) and eclampsia(64%). 
The majority of perinatal deaths 83.7% occurred 
among women with antepartum onset of PIH. 
Intra-partum and post-partum gestational age 
accounted for 32.4% and 8.1% respectively. 
Among the total perinatal deaths in 
antepartum period, there were 59.5%, 
24/74(32%) and 6/74(8.1%) perinatal mortalities 
at very preterm, preterm and term periods 
respectively. Among them, 93.2% were exposed 
to pregnancy induced hypertension.  From those 
exposed, very preterm and preterm accounted 
for 60.9% and 30.4% respectively. The 
premature perinatal death was more pronounced 
in eclamptic mothers than in preeclamptic 
mothers (50.7% and 26.1% respectively) (Table 
1). 
  
Table 1: Obstetrics and pregnancy induced hypertension related characteristics of women attending ANC 
in Gamo Zone public hospitals, Southern Ethiopia, 2018 (n=576). 
 
 









Parity Primigravida 11(5.72) 42(21.88) 1(0.3) 101(26.3) 
Multipara(I-IV) 44(22.9) 75(39.06) 2(0.5) 250(65.1) 
Grand Multipara(V+) 14(7.29) 6(3.1) 2(0.5) 28(7.3) 
Labor onset  Spontaneous 54(28.1) 90(46.9) 5(1.3) 349(90.9) 
Induced  10(5.2) 24(12.5) 0(0) 19(4.9) 
Direct CS 5(2.6) 9(4.7) 0(0) 11(2.9) 
Mode of delivery Vaginal 51(26.6) 99(51.6) 5(1.3) 352(91.7) 
Cesarean section 18(9.4) 24(12.5) 0(0) 27(7.0) 
Gestational Age(week) <34 42(21.9) 15(7.8) 2(0.5) 44(11.5) 
34-36 21(10.9) 27(14.1) 3(0.8) 120(31.3) 
>37 6(3.1) 81(42.2) 0(0) 215(56.0) 
Anticonvulsant provision Yes  54(28.1) 57(29.7) 0(0) 1(0.3) 
No 15(7.8) 66(34.4) 5(1.3) 378(98.4) 
Type of anticonvulsant 
(n=112) 
MgSO4 48(42.9) 42(37.5) 0(0) 0(0) 
Diazepam 6(5.4) 15(13.4) 0(0) 1(0.8) 
Perinatal Survival status: A total of 576 
perinates were followed for a minimum of four 
weeks and a maximum of 36 weeks with a 
median follow-up period of 14 weeks. 
Maximum of the respondents(18.6%) were 
followed for 20 weeks. In addition, 75(13%) of 
the women were followed for four weeks and 
6(1%), 1(0.2%) and 1(0.2%) of the women were 
followed for 28, 31 and 34 weeks respectively. 
The cumulative proportion of surviving at the 
end of 4th, 8th, 12th and 16th weeks of follow-up 
among the exposed groups were 96.9%, 93.5%, 
82.1% and 61.6% respectively whereas it was 
99.5%, 98.9% and 98.5% at 4th, 8th and 12th 
weeks of follow-up for the unexposed group 
respectively. The overall mean survival time was 
29.2[95%CI: 28.1, 30.4] weeks.(Figure 1).
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Figure 1: Kaplan-Meier survival estimate among mothers with pregnancy induced hypertension at ANC 
clinics of Gamo Zone public hospitals, Southern Ethiopia, 2018 (n=576). 
 
There was high number of perinatal mortality 
among the exposed group as compared to the 
unexposed group. As the gestational age 
increased, the perinatal mortality also increased 
among the mothers with PIH but as the 
gestational age increased, the survival 
probability increased among mothers who have 
no PIH (Figure 2). 
 
 
Figure 2: Difference in hazard of perinatal death between mothers with PIH and without PIH at ANC 
clinics of Gamo Zone public hospitals. 
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Comparison of survivor function between two 
or more group of perinates: The log-rank test 
result indicated that survival pattern or time to 
perinatal mortality significantly varied among 
the covariates of the perinatal mortality 
predictors. The overall mean survival time for 
parity and birth weight was 29.2[95%CI: 28.1, 
30.3] and 32.4[95%CI: 31.8, 33.0] respectively 
(Table 2). 
 
Table 2: The log-rank test estimate and the mean survival time between the covariates of the perinates 
among both the exposed and the non exposed groups. 
 
Variable  Category Mean survival time 
[95%CI] 
Log rank test 
Parity  Primigravida 28.7[27.6,29.9] x2=35.9, p-value=0.0001 
I-IV 29.3[27.9,30.7] 
>V 15.8[14.4,17.4] 
Gestational Age(week) <34 19.6[17.2,22.2] x2=117.3.9, p-value=0.0001 
35-36 24.3[23.1,25.7] 
>37 27.5[27.2,27.9] 
Number of ANC visits  1  19.3[14.7,24.4] x2=55.8, p-value=0.0001 
2 17.2[16.6.19.2] 
3  28.7[26.6,30.8] 
>4  28.2[27.3,29.2] 
Birth weight(gm) <2500 28.7[26.05,31.39] x2=29.3, p-value=0.0001 
>2500 30.1[29.68,30.60] 
Mode of delivery Vaginal 29.5[28.4,30.7] x2=12.6, p-value=0.002 
CS 23.3[21.4,25.1] 
Highest systolic blood 
pressure(mmHg) 
<140 31.4[30.4,32.5] x2=153.4, p-value=0.0001 
141-159 17.3[15.4,19.3] 
>160 15.1[12.7,17.4] 
Onset of pregnancy 
induced hypertension 
Pre partum 19.5[18.4,20.6] x2=103.7, p-value=0.0001 
Intra partum 19.2[17.9,20.5] 
Post-partum 18[16.0,19.9] 
Comparison of survivor function between two 
or more group of perinates among the 
exposed groups: The overall mean survival time 
for the variable parity was 
19.93(95%CI:18.97,20.89). Similarly, the 
overall mean survival time for gestational age 
was 23.84 (95%CI: 22.95, 24.74). In addition, 
the overall mean survival time for number of 
antenatal care visits, birth weight, mode of 
delivery, highest systolic blood pressure and 
onset of pregnancy induced hypertension was 
19.93(95%CI: 18.97,20.89), 22.59(95%CI: 
21.64,23.55), 19.93(95%CI: 18.97,20.88), 
19.93(95%CI: 18.97,20.89) and 19.93(95%CI: 
18.97,20.89) respectively. The specific mean 
survival time for each category of the variable 
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Table 3: The log-rank test result and the mean survival time among the covariates of the perinates 
delivered from the exposed groups. 
Variable  Category  Mean survival 
time(95%CI 
Log rank test estimate 





Gestational Age <34 15.75(14.15,17.36) X2=57.95, P-value=0.0001 
35-36 16.78(15.54,18.01) 
>37 23.84(22.95,24.74) 
Number of ANC visits One  10.00(8.53,11.47) X2=69.69, P-value=0.0001 
Two  11.08(10.09,12.07) 
Three  17.53(16.34,18.72) 
Four and above 21.75(20.81,22.71) 
Birth weight (gram) <2500 15.37(13.26,17.48) X2=20.68, P-value=0.0001 
>2500 23(84(23.13,24.56) 
Mode of delivery  Vaginal 20.08(18.99,21.17) X2=13.0, P-value=0.001 
Cesarean section 17.32(15.81,18.83) 
Highest systolic blood 
pressure(mmHg) 
<140 21.35(20.22,22.48) X2=20.69, P-value=0.0001 
141-159 17.74(15.88,19.59) 
>160 16.34(13.95,18.73) 
Onset of pregnancy 
induced hypertension 
Pre partum 19.56(18.49,20.64) X2=26.1, P-value=0.002 
Intra partum 19.28(17.97,20.58) 
Post-partum 18.00(16.04,19.96) 
 
Comparison of survivor function between two 
or more group of perinates among the non-
exposed groups:The mean survival time was 
different for each covariate of the unexposed 
group. The log rank test estimate was varied 
between the pooled estimate of the two groups 
and the unexposed group. The overall mean 
survival time for parity among the unexposed 
groups was 33.59 (95%CI: 33.25, 33.95). 
Similarly, the overall mean survival time for 
gestational age, number of antenatal care visits, 
birth weight and mode of delivery among the 
unexposed groups was 13.28 (95%CI: 12.67, 
13.89), 13.28 (95%CI: 12.67, 13.89), 13.27 
(95%CI: 12.66, 13.89) and 13.28 (95%CI: 
12.67, 13.89) respectively (Table 4). 
 
 
                  
                    Ethiop J Health Sci.                           Vol. 30, No. 6                          November 2020 
 




Table 4: The log-rank test estimate and the mean survival time among the covariates of the perinates 
delivered from the non-exposed groups 
 
Predictors of Perinatal mortality: This study 
revealed that parity, gestational age, number of 
ANC visits, birth weight, mode of delivery,	
highest systolic blood pressure and onset of 
hypertensive disorders of pregnancy were the 
independent predictors of perinatal mortality. 
The risk of perinatal mortality among 
women with parity of I-IV was twice higher 
compared to the primigravidas (AHR:2.1; 
95%CI: 1.01,4.3). Mothers with a party of five 
and above have 6.3 times higher risk of perinatal 
mortality compared to the primi gravidas(AHR: 
6.3; 95%CI: 1.36,10.55). Mothers who delivered 
before 34 weeks of gestation had 7.8 times 
higher risk of perinatal mortality compared to 
those of 37 weeks and above (AHR:7.8; 95%CI: 
2.6,23.1). Preterm's (34-36weeks of gestation) 
had 6 times higher risk of mortality compared to 
those of terms(37 weeks and above) AHR:6; 
95%CI: 5.3,19.2). Mothers who had one ANC 
visit had 8 times higher risk of perinatal 
mortality compared to those who had four and 
above visits (AHR: 8; 95%CI: 11.7,28.45). 
Similarly, mothers who had three and two ANC 
visits had 6.3 and 3.4 times higher risk of 
perinatal mortality as compared to four and 
above ANC visits (AHR; 6.3; 95%CI: 2.1, 18.7) 
and (AHR: 3.4; 95%CI: 2.1, 18.7) respectively.  
Perinates with birth weights below 
2500gm had 6.1 times higher risk of mortality 
compared to the counterparts who had 2500gm 
and above weight (AHR:6.1; 95&CI: 1.01,37.9). 
Mothers who delivered with a vaginal delivery 
had 2.7 times higher risk of perinatal mortality 
compared to those with who delivered with 
cesarean section (AHR: 2.7; 95%CI: 1.13, 6.84) 







Variable  Category  Mean survival 
time(95%CI) 
Log rank test estimate 





Gestational Age <34 10.71(8.67,12.75) X2=9.025, P-value=0.011 
35-36 13.34(12.21,14.47) 
>37 13.86(13.11,14.61) 
Number of ANC visits One  6.51(4.92,8.10) X2=23.985, P-value=0.0001 
Two  9.40(8.34,10.46) 
Three  12.72(11.75,13.68) 
Four and above 17.00(16.31,17.69) 
Birth weight  <2500 12.79(10.77,14.82) X2=44.31, P-value=0.0001 
>2500 13.33(12.69,13.97) 
Mode of delivery  Vaginal 13.16(12.54,13.79) X2=38.01, P-value=0.0001 
Cesarean section 14.78(12.11,17.44) 
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Table 5: Predictors of perinatal mortality among mothers with pregnancy induced hypertension at ANC 
clinics of Gamo Zone public hospitals, Southern Ethiopia(n=576). 
 
 
Variables Category Total Perinatal 
death (%) 
CHR(95%CI) AHR(95%CI) 
Residence Urban 458 12.7 1  
Rural 118 18.6 1.4(0.9,2.3)*  
Parity Primigravida 156 8.3 1 1 
I-IV 370 12.4 1.5(0.8,2.9)* 2.1(1.01,4.3)** 
>V 50 32 6.3(2.9,13.3)* 3.7(1.36,10.55)** 
Gestational 
age(week) 
Very preterm(<34) 103 42.7 25(10.7,58.8)* 7.8(2.6,23.1)*** 
Preterm(34-36) 171 14.0 8.8(0.36,21.5) 6(5.3,19.2)*** 
Term(>37) 302 1.99 1 1 
Number of ANC 
visits 
One visit 74 16.2 10(5.1,21)* 8(11.7,28.45)*** 
Two visit 88 9.1 3.4(1.5,7.6)* 6.3(2.1,18.7)*** 
Three visits 142 14.1 2.1(1.5,7.6)* 3.4(1.6,6.8)*** 
Four and above visits 272 12.5 1 1 
Birth weight(gram) <2500 70 18.6 6.4(2.9,14.1)* 6.1(1.01,37.9)** 
>2500 457 2.6 1  
Labour onset Spontaneous 498 11.8 0.86(0.34,2.15)  
Induced  53 18.9 0.96(0.33,2.83)  
Direct cesarean section 25 20 1  
Mode of delivery Vaginal 507 11.0 1.9(1.1,3.24)* 2.7(1.13,6.84)** 
Cesarean section 69 26.1 1 1 
Number of fetus Single tone 557 12.7 1  
Twin 19 15.8 1.1(0.36,3.63)  
Maternal hemoglobin 
level(mg/dl) 
<10 54 11.1 0.79(0.34,1.84)  
10-11.9 68 17.6 1.39(0.75,2.61)  
>12 454 12.3 1  
            Key note: * p-value <0.25, ** p-value <0.05, *** p-value <0.001 
Table 6: Pregnancy induced hypertension related predictors of perinatal mortality among mothers with 
PIH at ANC clinics of Gamo Zone public hospitals. 
 




Highest systolic blood 
pressure(mmHg) 
<140 498 4.2 1 1 
141-159 37 59.5 8.6(4.9,14.9)*  
>160 41 75.6 11.6(6.7,20)* 2.3(1.02,5.55)** 
Highest Diastolic blood 
pressure(mmHg) 
<90 478 2.3 1  
90-110 46 41.3 4.2(2.4,7.2)*  
>110 52 84.6 6(3.1,11.7)*  
Onset of pregnancy induced 
hypertension 
Pre partum 158 39.2 5(0.01,0.27)* 3(0.004,0.239)*** 
Intra partum 14 35.7 1.3(0.3,5.1) 0.77(0.15,3.8) 
Post-partum 20 10 1 1 
Type of pregnancy induced 
hypertension 
Mild preeclampsia 100 10 1  
Sever preeclampsia 61 63.9 5.5(1.9,16.3)*  
Eclampsia 31 64.5 4.6(18,118)*  
Having severity symptoms Yes  74 55.4 3.2(1.9,2.9)*  No 118 27.9 1  
Type of anticonvulsant 
provided 
MgSO4 48 87.5 1  
Diazepam 64 25 10(6.4,18.5)*  
             Key note: * p-value <0.25, ** p-value <0.05, *** p-value <0.001 
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Mothers who had the highest systolic blood of 
PIH had 3 times higher risk of perinatal 
mortality compared to those of postpartum onset 
(AHR pressure 160mmHg and above have 2.3 
times higher risk perinatal mortality compared to 
those who had 140mmHg and below (AHR:2.3; 
95%CI: 1.02,5.55). Mothers who have a 




Consistent with previous study findings, this 
study indicated that there was a high perinatal 
mortality among mothers with PIH 
(10,11,12,13). However, the perinatal mortality 
rate in this study was lower than the study report 
from Jimma, Ethiopia, and Hawassa University 
Teaching Hospitals (1,14), but which is greater 
than the study reports from Pakistan, Turkey and 
Addis Ababa (11,15,16). This might be due to 
the increased focus of the government and other 
stakeholders, variation in the implementation 
strategies across the globe and increased 
awareness and knowledge on PIH.  
Specific to the objective of this study, 
the analysis demonstrated the independent 
predictors of perinatal mortality.  In 
multivariable cox proportional hazard model, 
parity, gestational age, number of ANC visit, 
birth weight, mode of delivery, highest systolic 
blood pressure and onset of PIH were 
statistically significant. 
In this study, an increase in the risk of 
perinatal mortality due to an increase in parity 
was observed. The finding of this study was 
consistent with other studies conducted in 
Hawassa University Teaching Hospital, which 
revealed that multiparas (I-IV) had 1.6 and 
grand multiparas had 2.8 times higher risk of 
perinatal mortality compared to primigravidas 
(14). Similarly, a study conducted at Derashe 
District revealed that grand multiparas had 4 
times higher risk of perinatal mortality 
compared to the primigravidas (17). This might 
be due to the fact that multi-parity may 
predispose the mother to anemia, Diabetes 
Mellitus (DM), mal-presentation, abruption of 
placenta, placenta previa, post-partum 
hemorrhage due to uterine atony and uterine 
rupture (18,19,20). 
The significantly increased risk of perinatal 
mortality among babies with low gestational age 
and low birth weight in this study is consistent 
with several other studies (14, 21, 22, 23). This 
finding shows a strong association of perinatal 
mortality among babies delivered from mothers 
having antepartum onset of PIH. More than two-
thirds of the perinatal deaths (91%) in women 
with antepartum onset of PIH were either 
preterm or very preterm at birth. This might be 
due to the fact that PIH probably exposed 
several babies to premature delivery and related 
complications. Inconsistent with this study, 
other studies revealed that there was an 
increased risk of premature delivery in mothers 
with PIH and also the perinatal deaths observed 
on eclamptic mothers were commonly caused by 
prematurity of the newborn(23, 24). 
In line with the study conducted in 
Southern Ethiopia, Jewish and Kerman 
(14,25,26), the finding of this study revealed that 
the risk of perinatal death decreased as the 
number of ANC visits increased. This perinatal 
mortality might be due to the delay in 
recognition and initiation of interventions. The 
delay in providing treatment in the early stage of 
the disease is likely to progress to severe stage 
of the disease like severe preeclampsia and 
eclampsia, which was in turn found to have a 
strong association with perinatal mortality.  
Similar with other studies, this finding 
revealed that mothers who gave birth through 
vaginal delivery had a higher risk of perinatal 
mortality compared to the counterparts by 
cesarean delivery. This might be due to cesarean 
delivery results in an expeditious delivery and 
also it has reduced risk of complications 
associated with PIH and perinatal mortality (14). 
In addition, the strong association of perinatal 
mortality with vaginal delivery may not 
necessarily show the increased risk because 
most of the still births occurred before the onset 
of labor or before CS was considered. 
This study revealed that women with a 
preparum onset of PIH had higher risk of 
perinatal mortality. This is probably due to the 
early occurrence of PIH; it has a high 
opportunity to develop complications and to 
have eclampsia. Due to the severe nature of 
eclampsia, which potentially complicate the 
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problem by severe intrauterine asphyxia, severe 
placental abruption and neonatal sepsis (27). In 
addition, the antepartum onset of PIH accounted 
for most of the perinatal deaths (91%) of deaths 
among mothers with pregnancy induced 
hypertension. 
Mothers who had the highest systolic 
blood pressure of 160 and above had two folds 
increased risk of perinatal mortality. This might 
be due to the fact that complications associated 
with PIH were elicited when the range of highest 
blood pressure increased.  
Similarly, this study did not indicate a 
statistically significant association of perinatal 
mortality with type of anticonvulsant given. 
Also, another study reported that there was no 
difference in perinatal mortality between 
diazepam and magnesium sulphate groups 
(14,28). Another study, however, showed that 
women with diazepam had 3 times higher risk of 
perinatal death compared to women with 
magnesium sulphate (29). Also, it is noted that 
magnesium sulphate is better in preventing and 
controlling convulsion in women presenting 
with PIH (30), which indirectly prevents 
perinatal death through controlling eclampsia. 
However, these inconsistent findings need meta-
analysis.  
The limitation of this study was that 
since the study was conducted through record 
review, some variables related with laboratory 
tests, socio-economic, socio-demographic and 
service related factors were missed. Similarly, 
the measurements for antepartum and post-
partum care were not comprehensive, 
particularly in relation to referral and medication 
unavailability. 
In conclusion, the multivariable analysis 
indicated that high parity, low gestational age, 
low number of ANC visits, low birth weight, 
vaginal delivery, antepartum onset of HDP and 
highest systolic blood pressure more than 
160mmHg were the independent predictors of 
perinatal mortality. The government should 
highly encourage the pregnant mothers to reduce 
the number of births and educated on ANC visits 
to early determine PIH. In addition, the hospitals 
should give due attention to early determination 
and initiate treatment of PIH. On the other hand, 
follow up of mothers under PIH should be 
strengthened by the health professionals. 
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